$MDT (Medtronics) earnings were better than expected, however a review of the earnings report does not change our medium term thesis. Unless our methodology tells us otherwise, we will use spikes up to add ...
$BSX (BOSTON SCIENTIFIC) EARNINGS CONFIRM OUR SHORT SELL THESIS
We have been short on $MDT (Medtronics) with the first scale in at $36.20 and more aggressive entry at $38.00. $BSX earnings show weakness in both stents and implantable cardiac devices. Going forward ...
CONSIDER SHORT SELL ON MDT (MEDTRONICS)
Consider start scaling in a short position in MDT right here at $36.20. MDT had passed all of our screens for a short sale, but we had been waiting for a trigger that the market ...
CHECK OUR PERFORMANCE
